You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Risk factors for prolonged fever following macrolide treatment

From: Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia

Parameters Fever duration following macrolide treatment Univariate model Multivariate model
<7 days (N = 79) ≥7 days (N = 37) P aORa P 95% CI
Male gender 40 (50.6) 19 (51.4) 0.942    
Age in years, mean ± SD 5.8 ± 3.2 6.3 ± 3.9 0.499    
Macrolide resistance 51 (64.6) 31 (83.8) 0.034 2.687 0.072 0.917–7.878
Extrapulmonary signs 9 (11.4) 12 (32.4) 0.006 3.037 0.039 1.057–8.726
Radiology findings
 Lobar consolidation 21 (26.6) 23 (62.2) 0.000 3.610 0.004 1.519–8.580
 Patchy consolidation 27 (34.2) 10 (27.0) 0.441    
 Nodular opacities 15 (19.0) 4 (10.8) 0.420    
 Parahilar infiltration 16 (20.3) 0 (0) 0.003    
 Parapneumonic effusion 5 (6.3) 17 (45.9) 0.000 9.705 0.000 3.031–31.075
  1. Data are no. (%) of patients, unless otherwise indicated
  2. aAdjusted odds ratio